Larissa Meyer

Larissa Meyer


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2025 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Open access
MLMujia Jenny Li
Mujia Jenny Li
LMLarissa Meyer
Larissa Meyer
NMNadine Meier
Nadine Meier
JWJannik Witte
Jannik Witte
MMMaximilian Maldacker
Maximilian Maldacker
MFMelanie Foell
Melanie Foell
Rationale: In spatial proteomics, matrix‐assisted laser desorption/ionization (MALDI) imaging enables rapid and cost‐effective peptide measurements. Yet, in situ peptide identification remains challenging. Therefore, this study aims to integrate the trapped ion mobility spectrometry (TIMS)–based parallel accumulation‐serial fragmentation (PASEF) into MALDI imaging of tryptic peptides to enable multiplexed MS/MS imaging. Methods: An initial MALDI TIMS MS1 survey measurement was performed, followed by a manual generation of a precursor list containing mass over charge values and ion mobility windows. Inside the dual TIMS system, submitted precursors were trapped, separately eluted by their ion mobility and analyzed in a quadrupole time‐of‐flight device, thereby enabling multiplexed MALDI MS/MS imaging. Finally, precursors were identified by peptide to spectrum matching. Results: This study presents the first multiplexed MALDI TIMS MS/MS imaging (iprm‐PASEF) of tryptic peptides. Its applicability was showcased on two histomorphologically distinct tissue specimens in a four‐plex and five‐plex setup. Precursors were successfully identified by the search engine MASCOT in one single MALDI imaging experiment for each respective tissue. Peptide identifications were corroborated by liquid–chromatography tandem mass spectrometry experiments and fragment colocalization analyses. Conclusions: In this study, we present a novel pipeline, based on iprm‐PASEF, that allows the multiplexed and spatial identification of tryptic peptides in MALDI imaging. Hence, it marks a first step towards the integration of MALDI imaging into the emerging field of spatial proteomics.

8 November 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
MLMujia Jenny Li
Mujia Jenny Li
LMLarissa Meyer
Larissa Meyer
NMNadine Meier
Nadine Meier
JWJannik Witte
Jannik Witte
MMMaximilian Maldacker
Maximilian Maldacker
MFMelanie Foell
Melanie Foell
RATIONALE: In spatial proteomics, matrix-assisted laser desorption/ionization (MALDI) imaging enables rapid and cost-effective peptide measurements. Yet, in situ peptide identification remains challenging. Therefore, this study aims to integrate the trapped ion mobility spectrometry (TIMS)-based parallel accumulation-serial fragmentation (PASEF) into MALDI imaging of tryptic peptides to enable multiplexed MS/MS imaging. METHODS: An initial MALDI TIMS MS1 survey measurement was performed, followed by a manual generation of a precursor list containing mass over charge values and ion mobility windows. Inside the dual TIMS system, submitted precursors were trapped, separately eluted by their ion mobility and analyzed in a quadrupole time-of-flight device, thereby enabling multiplexed MALDI MS/MS imaging. Finally, precursors were identified by peptide to spectrum matching. RESULTS: This study presents the first multiplexed MALDI TIMS MS/MS imaging (iprm-PASEF) of tryptic peptides. Its applicability was showcased on two histomorphologically distinct tissue specimens in a 4-plex and 5-plex setup. Precursors were successfully identified by the search engine MASCOT in one single MALDI imaging experiment for each respective tissue. Peptide identifications were corroborated by liquid-chromatography tandem mass spectrometry experiments and fragment co-localization analyses. CONCLUSIONS: In this study, we present a novel pipeline, based on iprm-PASEF that allows the multiplexed and spatial identification of tryptic peptides in MALDI imaging. Hence, it marks a first step towards the integration of MALDI imaging into the emerging field of spatial proteomics.

25 August 2026 in Bioinformatics
Verified
Journal Article
Open access
YZYinyue Zhu
Yinyue Zhu
KBKylie Ariel Bemis
Kylie Ariel Bemis
SLSai Srikanth Lakkimsetty
Sai Srikanth Lakkimsetty
MLMujia Jenny Li
Mujia Jenny Li
LMLarissa Meyer
Larissa Meyer
OVOlga Vitek
Olga Vitek
Summary: Mass spectrometry imaging (MSI) enables high-throughput spatial mapping of molecules, but the lack of chromatographic separation limits its utility for complex biological samples. Ion mobility (IM) provides key orthogonal separation. However, open-source tools dedicated for IM-MSI data analysis remain scarce and the integration of ion mobility information into downstream analysis is underexplored. Here, we present TIMSImaging, an open-source workflow for processing and visualization of MALDI-TIMS-MS data from Bruker timsTOF instruments. TIMSImaging incorporates a graph-based two-dimensional feature extraction algorithm for separation of isobaric peaks by ion mobility, supports collision cross section (CCS) calculation, and exports results as imzML files with ion mobility for downstream analysis. We demonstrate its capabilities on three case studies spanning different sample types, analyte types, and downstream tasks. Availability and implementation: TIMSImaging is released as open-source software under the MIT License. The source code, installation instructions, documentation, and case study Vignettes are available at https://github.com/YinyueZhu/TIMSImaging

6 September 2025 in bioRxiv
Verified
Preprint
Open access
LMLarissa Meyer
Larissa Meyer
MLMujia Jenny Li
Mujia Jenny Li
NMNadine Meier
Nadine Meier
BVBeate Vollmer-Kary
Beate Vollmer-Kary
TFTobias Feilen
Tobias Feilen
OSOliver Schilling
Oliver Schilling
Background: Amyloidosis collectively describes a heterogeneous group of protein aggregation-based diseases involving the misfolding and extracellular accumulation of fibril-forming amyloid proteins. The tissue deposition of these fibrils occurs either localized (limited to one organ) or systemically, impairing organ function and, in severe cases, leading to organ failure. Identification of the amyloidogenic protein leading to the correct subtyping is challenging but crucial for treatment decisions. Imaging parallel reaction monitoring (iprm)-parallel accumulation-serial fragmentation (PASEF) is a novel method for matrix-assisted laser desorption/ionization (MALDI)-mass spectrometry imaging (MSI) that enables the fast, spatially resolved, multiplexed, and antibody-independent identification of peptides and proteins in situ. In this proof-of-concept study, we demonstrate the applicability of iprm-PASEF for the in situ characterization of amyloidosis. Methods: A multiplexed iprm-PASEF panel (comprising trapped ion mobility spectrometry (TIMS) and m/z values) for characterizing amyloid plaques by MALDI-MSI was compiled. The panel included nine peptide entries of amyloidosis-associated proteins (vitronectin, apolipoprotein E, serum amyloid P component) and the prevalent amyloidosis-subtype proteins serum amyloid A, transthyretin, and immunoglobulin light chain 2. The multiplexed iprm-PASEF panel was applied to a tissue microarray (TMA) assembled from formalin-fixed, paraffin-embedded (FFPE) specimens, comprising biopsies of amyloidosis-positive tissues from 18 patients, including six different tissue types, and representing the following amyloidosis subtypes: ATTR (transthyretin amyloidosis), AL (immunoglobulin light chain amyloidosis), and AA (secondary amyloidosis). For comparison and co-localization, congo red staining was performed on adjacent slides. Results: MALDI TIMS MS1 imaging was acquired from the amyloidosis TMA, providing an m / z feature list containing 1390 entries that was subsequently refined to only include m / z features likely stemming from amyloidosis-related peptides. Further, we focused on optimal usage of the m / z and ion mobility range to increase the number of targeted peptides. The final iprm-PASEF panel comprised 10 entries ranging from m / z 887.51 - 1,986.85 and 1/ K 0 1.4 - 2.1 V·s/cm 2 ; targeting nine peptides from six different amyloidosis-related proteins. Apolipoprotein E, serum amyloid P component, and immunoglobulin light chain 1/2 were included with two entries. Transthyretin, vitronectin, and serum amyloid A were covered by one peptide. One entry was included as a positive control targeting actin A. We applied the iprm-PASEF (MS2 mode) panel to the amyloidosis TMA and fragment (MS2) spectra were analyzed by the search engine MASCOT. Eight out of ten peptides derived from vitronectin, apolipoprotein E, serum amyloid A, serum amyloid P component, and transthyretin were successfully identified with MASCOT scores above 18. Comparison to Congo red staining indicated a more localized and heterogeneous pattern of amyloid-associated proteins (vitronectin, apolipoprotein E, serum amyloid P component) by iprm-PASEF. Compared to the clinical annotation, transthyretin and serum amyloid A were only found in their respective subtypes. In total, it was possible to describe the spatial distribution of five different amyloid-associated proteins, thereby further characterizing Congo red-positive amyloid plaques in one single iprm-PASEF measurement. Conclusion and perspective: This proof-of-concept study demonstrates feasibility for in situ, antibody-independent, and multiplexed proteomic typing of amyloidosis plaques. Future enlargement of the multiplex panel is likely to increase the number of targetable amyloid proteins and to probe for the presence of post-translational modifications. The present study highlights the value of iprm-PASEF for MALDI imaging strategies.

7 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
LMLarissa Meyer
Larissa Meyer
MLMujia Jenny Li
Mujia Jenny Li
OSOliver Schilling
Oliver Schilling
MFMelanie Foell
Melanie Foell
Spatial proteomics has become an important approach for studying the molelccular composition of tissues while preserving their spatial context. Among the available technologies, tryptic peptide MALDI imaging enables fast, multiplexed, label-free, and antibody-independent protein analysis directly from tissue sections. However, confident peptide identification remains one of the major challenges of current MALDI imaging workflows, as most experiments are limited to MS1 acquisition and therefore lack in situ peptide fragmentation and amino acid sequence information. Consequently, peptide identification often relies on complementary (LC-)MS/MS analyses, which do not always enable unambiguous peptide assignment.Recent advances in trapped ion mobility spectrometry (TIMS) and parallel accumulation-serial fragmentation (PASEF) enable multiplexed, in situ, targeted peptide fragmentation during MALDI imaging experiments. By combining an exploratory TIMS-MS1 survey with targeted precursor selection and imaging parallel reaction monitoring (iprm)-PASEF acquisition, reliable peptide identification can be achieved in MALDI imaging.In this chapter, we describe a detailed protocol for targeted tryptic peptide MS/MS-based MALDI imaging using iprm-PASEF on the timsTOF fleX mass spectrometer. The workflow consists of tissue preparation with in situ protein digestion, followed by exploratory MALDI TIMS-MS1 imaging, precursor list generation, iprm-PASEF acquisition, and subsequent peptide identification. In addition, practical considerations for instrumental setup, precursor selection, and data analysis are discussed to facilitate implementation of the workflow for spatial proteomics applications.